BCG
GSK icon

BayBridge Capital Group’s GSK GSK Stock Holding History

BayBridge Capital Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,086
Closed -$453K – 96
2024
Q3 		$453K Buy
11,086
+807
+8% +$33K 0.33% 76
2024
Q2 		$396K Buy
10,279
+187
+2% +$7.87K 0.31% 78
2024
Q1 		$410K Buy
+10,092
New +$416K 0.36% 72

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BayBridge Capital Group's GSK Position: Q4 2024 in Review

BayBridge Capital Group sold out of GSK (GSK) in Q4 2024, closing a stake of 11,086 shares — an estimated $453K sold.

BayBridge Capital Group first reported a position in GSK in Q1 2024 and held it in 3 quarters. The position peaked at $453K in Q3 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • BayBridge Capital Group reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • BayBridge Capital Group sold 11,086 GSK shares in Q4 2024, an estimated $453K.
  • BayBridge Capital Group first reported a position in GSK in Q1 2024 and held it in 3 quarters.
  • BayBridge Capital Group's GSK position peaked at $453K in Q3 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on BayBridge Capital Group's 13F filing for Q4 2024, filed 28 Jan 2025.